FOR IMMEDIATE RELEASE
CONTACT:
Karen Jones
2424 SE Bristol St. Ste. 250
Newport Beach, CA 92660
(949)428-7081
Five Year Old Organization Makes a Big Impact by Awarding $250,000 through a Partnership with the AACR
Newport Beach, CA, July 2012: Kure It, a non-profit organization dedicated to supporting underfunded cancer research, will partner with the AACR to award $250,000 through a competitive grants process. The AACR-Kure It Grant for Kidney Cancer Research represents a joint effort to promote and support innovative cancer research. Independent investigators will be invited to apply for funding to develop and study novel ideas and approaches that have direct application and relevance to kidney cancer patients. The funding will cover a two year period, and the project will be selected by an expert panel of kidney cancer specialists assembled by the AACR.
The AACR is the oldest and largest scientific organization in the world focused on every aspect of high-quality, innovative cancer research. The organizations share the goal of creating a grant program that has lasting value and high prestige within the world of science and beyond. Both organizations are committed to sustaining the grant in a collaborative fashion to award research dollars to the most promising kidney cancer research project. Karen Jones, Director of Kure It, stated, "We are proud to be joining hands with an organization as well respected as the AACR, and look forward to putting these dollars to work in the lab. Those who support Kure it can be sure their gifts will have a larger reach and impact through the partnership.”
As the cosponsor and grant administrator, the AACR will conduct a competitive grant application process. The grant will be awarded to a project that demonstrates innovative translational research designed to improve the survival and quality of life for patients with kidney cancer, leads to individualized therapeutic options for treatment, or focuses on the development of promising new cancer therapeutics for kidney cancer. More information about the grant opportunity is available on the AACR website. Applications will be accepted until noon ET on August 21, 2012.
###
About Kure It
Kure It is a non-profit organization whose mission is to raise money for cancer research specialists conducting innovative projects to better treat and ultimately cure kidney cancer and other underfunded malignancies. Kure It has raised over $1 million for research since being founded in 2007. Kure It supports research at major institutions, including Samuel Oschin Cancer Center at Cedars Sinai; Beckman Research Institute at the City of Hope; and Knight Research Institute at Oregon Health Sciences University.
About the AACR
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR’s membership includes 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 17,000 attendees. In addition, the AACR publishes seven peer-reviewed scientific journals and a magazine for cancer survivors, patients and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration and scientific oversight of individual and team science grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer.
For more information about the AACR, visit www.AACR.org.
